InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,909.60
(
0.08%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.65
(
-0.90%
)
Bitcoin
57,927.27
(
2.15%
)

Replies to post #662 on Clinical Data (CLDA)

Replies to #662 on Clinical Data (CLDA)

pcrutch

01/24/11 7:30 PM

#663 RE: Autosinger #662

"The drug will be marketed as Viibryd by Clinical Data subsidiary Trovis Pharmaceuticals, formerly known as PGxHealth, and will be available during the second quarter of this year."